Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,46 USD | +10,61% |
|
+14,06% | +3,55% |
Attività
Numero di dipendenti: 83
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Mental Health Innovations
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +34,76% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States and Germany
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +34,76% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Florian Brand
CEO | Chief Executive Officer | 37 | 01/06/18 |
Srinivas Rao
CEO | Chief Executive Officer | 55 | 01/06/18 |
Anne Johnson
DFI | Director of Finance/CFO | 55 | 01/01/21 |
Kevin Craig
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Arvind Tewari
COO | Chief Operating Officer | 39 | 01/01/21 |
Frank Stegert
CIO | Chief Investment Officer | 41 | - |
Samantha Bender
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Chief Tech/Sci/R&D Officer | 55 | 01/01/20 | |
Chris Lee
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Michael Raven
COO | Chief Operating Officer | - | 01/01/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Sabrina Johnson
BRD | Director/Board Member | 57 | 01/01/21 |
Founder | 45 | 01/06/18 | |
Amir Kalali
BRD | Director/Board Member | 58 | 01/01/23 |
Andrea Smiley
BRD | Director/Board Member | 56 | 01/01/21 |
Michael Auerbach
BRD | Director/Board Member | 48 | 01/06/21 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 167 406 070 | 150 647 814 ( 89,99 %) | 0 | 89,99 % |
Partecipazioni
Nome | Azioni | % | Valorizzazione |
---|---|---|---|
INTELGENX TECHNOLOGIES CORP. 21.36% | 37 300 000 | 21.36% | 1 492 000 $ |
Coordinate società
![Indirizzo Atai Life Sciences N.V.(ATAI)](https://cdn.zonebourse.com/static/address/123820658.png)
Società del gruppo
Nome | Categoria e settore |
---|---|
ATAI Life Sciences AG
![]() ATAI Life Sciences AG Pharmaceuticals: MajorHealth Technology ATAI Life Sciences AG operates as a holding company, which is a global biotech company builder. The company was founded by Christian Angermayer, Lars Christian Wilde, Srinivas G. Rao and Florian Brand in 2018 and is headquartered in Munich, Germany. |
Pharmaceuticals: Major
|
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+3,55% | 244 Mln | |
+23,50% | 47,07 Mrd | |
+47,75% | 42,06 Mrd | |
-5,16% | 39,98 Mrd | |
+36,37% | 33,02 Mrd | |
-7,79% | 27,9 Mrd | |
+18,06% | 27,63 Mrd | |
+47,29% | 14,37 Mrd | |
+41,91% | 13,45 Mrd | |
-1,02% | 12,03 Mrd |
- Borsa valori
- Azioni
- Azione ATAI
- Società Atai Life Sciences N.V.